ST PHARM
ST PHARM is a family company of the Dong-A Sosio Group, which has a history of 80 years in the domestic market . It produces excellent APIs with the mission of 'endless challenge for human health and happiness' I want to. The company is pursuing contract development and manufacturing (CDMO) projects that involve research and development with global pharmaceutical companies, beyond simple consignment production. Through accumulated research and technological expertise, They supply raw material ... pharmaceuticals to domestic and overseas pharmaceutical companies. In addition, through active investment and system construction, they are operating an international quality and production system certified by cGMP from regulatory agencies such as US FDA, EMA, as well as MFDS in Korea. In the meantime, as a result of constant investment and technological development, the company has been selected as an Advanced Technology Center (ATC), an innovative pharmaceutical company, and a World Class 300 company. Have been recognized.
ST PHARM
Social Links:
Industry:
Manufacturing Pharmaceutical
Founded:
1983-01-01
Status:
Active
Contact:
+82 25276300
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Content Delivery Network LetsEncrypt Amazon SSL By Default Nginx
Similar Organizations
Officina Profumo Farmaceutica di Santa Maria Novella
Santa Maria Novella's Officina Profumo Farmaceutica offers exquisite perfumes and skincare items produced with medical plants.
Current Employees Featured
Investors List
Shinhan Venture Investment
Shinhan Venture Investment investment in Venture Round - ST Pharm
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-22 | Pinot Bio | ST Pharm investment in Venture Round - Pinot Bio | 6 B KRW |
| 2020-12-14 | Autotelic Bio | ST Pharm investment in Series A - Autotelic Bio | N/A |
More informations about "ST Pharm"
All - ST PHARM
ST PHARM News '100-Day Expedite Strategy', Preparedness and Proactive Measures for Future Pandemic Nov 21, 2023. ST PHARM News 'To Become a Global Korean CDMO' - 2023 …See details»
St Pharm | Company Overview & News - Forbes
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic …See details»
ST Pharm Co., Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
About ST Pharm ST Pharm is a technology-driven CDMO, specializing in the development, manufacturing, and commercialization of oligonucleotides, mRNA, and small molecule APIs. …See details»
ST PHARM to Supply Lipids to Biotech in North America
May 4, 2022 ST Pharm announced on May 3 that it has signed a lipid supply contract worth 17.7 billion won with Biotech in North America, starting its global mRNA consignment development …See details»
ST PHARM - LinkedIn
ST PHARM | 2,016 followers on LinkedIn. “ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.”See details»
ST Pharm - Crunchbase Investor Profile & Investments
ST PHARM is a family company of the Dong-A Sosio Group, which has a history of 80 years in the domestic market . It produces excellent APIs with the mission of 'endless challenge for human health and happiness' I want to. The company is …See details»
Kyungjin Peter Kim – CEO, ST Pharm, South Korea
ST Pharm was established in 1983 as “Samchully Pharma” and has been doing business in the field of active pharmaceutical ingredients (API) and it is a key intermediate CMO (Contract Manufacturing Organization). In 2010, we …See details»
ST Pharm Co. Ltd. Stock Overview (S. Korea: KRX) - Barron's
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic …See details»
ST Pharm, Top CDMOs in APAC-2022 - Pharma Tech …
ST Pharm Co. Ltd. is an Active Pharmaceutical Ingredient (API) contract development and manufacturing organization (CDMO) in the Republic of Korea and is a one-stop shop for mRNA drug development, Non-clinical animal …See details»
ST Pharm aims to lead oligonucleotide production by …
Oct 29, 2023 BARCELONA, Spain — Bio-manufacturer ST Pharm is seeking to secure the world’s top-notch production capacity for oligonucleotide by 2026. The contract development and manufacturing organization (CDMO) is currently …See details»
ST Pharm Co., Ltd. ESG Risk Rating - Sustainalytics
St Pharm Co Ltd offers custom manufacturing services of Active pharmaceutical ingredients and their intermediates for their use in pharmaceutical development and be compliant to cGMP, …See details»
ST PHARM | LinkedIn
ST PHARM | 2,016 followers on LinkedIn. “ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication …See details»
ST Pharm breaks ground on 2nd oligonucleotide manufacturing …
ST Pharm said it has taken its first step towards becoming the global leader in the oligonucleotide contract development and manufacturing organization (CDMO) domain with the …See details»
IR Materials - ST PHARM
[Earnings Summary] ST PHARM 4Q. 2022 Earnings Summary Feb 17, 2023 [Presentation] ST PHARM IR Preentation (Feb. 2023) Feb 6, 2023 [Analyst Report] Fundamentals intact despite …See details»
ST Pharm and Quantoom Biosciences Announce a First Supply …
Aug 20, 2024 ST Pharm’s nucleic acid platform includes process development, analytical development, and manufacturing services that are enhanced by the supply of critical raw …See details»
Investing in mRNA platforms to create CDMO–biotech partnership ...
ST PHARM developed two mRNA platform technologies to facilitate its expansion. The development work has given the company 5′-capping analogs, marketed as SmartCap, and a …See details»
ST Pharm in talks with Moderna over contract ... - The Korea Times
Jun 1, 2021 ST Pharm declined to comment on the possibility of signing a contract manufacturing organization (CMO) deal with Moderna. "ST Pharm plans to apply liquid …See details»
Korea-based ST Pharm takes leap towards world's largest …
Nov 30, 2021 ST Pharm Co. Ltd., an Active Pharmaceutical Ingredient (API) contract development and manufacturing organization (CDMO) in Republic of Korea, has announced to …See details»
IVI, ST Pharm exchange MOU on clinical development of COVID …
November 24, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and ST Pharm announced November 24 that they exchanged a memorandum of understanding to …See details»
Exceptional St. John’s Pharmaceutical ... - St. John's University
1 day ago December 11, 2024. Two doctoral candidates at St. John’s University’s College of Pharmacy and Health Sciences won national student awards recently at the 2024 Annual …See details»